drugset / Trial / NCT06569394

A Study of Cannabidiol in Young Adult Cannabis Users

NCT06569394

RandomizedParallel-groupQuadruple-blindOther

Summary

The investigators will study the harm-reducing effect of hemp-derived CBD in non-treatment-seeking emerging adults who use cannabis regularly. The study will use a novel naturalistic cannabis administration approach, which examines ecologically valid cannabis use utilizing a mobile lab setting to assess the effects of the cannabis products the participants regularly use. The investigators will recruit a sample of emerging adults, half of whom primarily use flower products and half of whom primarily use concentrate products. Individuals will be randomly assigned to hemp-derived CBD or placebo.

Timeline

Start
2024-12-09
Primary completion
2028-06-30
Completion
2028-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cannabidiol Other / unclassified 400 mg Oral

Indications